Request Demo
Last update 09 May 2026
Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)
Last update 09 May 2026
Overview
Basic Info
Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)NCT06614270
Clinical Study of Core Blood-derived Anti-CD19 IL-10/IL15 CAR-NK in the Treatment of Refractory/Relapsed Autoimmune Diseases
NCT06707259
Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL
100 Clinical Results associated with Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)
Login to view more data
100 Translational Medicine associated with Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)
Login to view more data
100 Patents (Medical) associated with Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)
Login to view more data
100 Deals associated with Anti-CD19 IL-10/IL15 CAR-NK Cells(The Second Affiliated Hospital Zhejiang University)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mediastinal large B-cell lymphoma | Phase 1 | China | 01 Dec 2024 | |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Clinical | China | 06 Jan 2025 | |
| Antiphospholipid Syndrome | Clinical | China | 06 Jan 2025 | |
| Idiopathic Inflammatory Myopathies | Clinical | China | 06 Jan 2025 | |
| Scleroderma, Systemic | Clinical | China | 06 Jan 2025 | |
| Sjogren's Syndrome | Clinical | China | 06 Jan 2025 | |
| Systemic Lupus Erythematosus | Clinical | China | 06 Jan 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free